Here is the relevant section of US Code
21 U.S. Code § 360bbb–3 - Authorization for medical products for use in emergencies:
- (e) Conditions of authorization
- (1) Unapproved product
- (A) Required conditions
- With respect to the emergency use of an unapproved product, the Secretary, to the extent practicable given the applicable circumstances described in subsection (b)(1), shall, for a person who carries out any activity for which the authorization is issued, establish such conditions on an authorization under this section as the Secretary finds necessary or appropriate to protect the public health, including the following:
- (i)Appropriate conditions designed to ensure that health care professionals administering the product are informed—
- (I) that the Secretary has authorized the emergency use of the product;
- (II) of the significant known and potential benefits and risks of the emergency use of the product, and of the extent to which such benefits and risks are unknown; and
- (III) of the alternatives to the product that are available, and of their benefits and risks.
- (ii)Appropriate conditions designed to ensure that individuals to whom the product is administered are informed—
- (I) that the Secretary has authorized the emergency use of the product;
- (II) of the significant known and potential benefits and risks of such use, and of the extent to which such benefits and risks are unknown; and
- (III) of the option to accept or refuse administration of the product, of the consequences, if any, of refusing administration of the product, and of the alternatives to the product that are available and of their benefits and risks.
- (iii) Appropriate conditions for the monitoring and reporting of adverse events associated with the emergency use of the product.
- (iv)cFor manufacturers of the product, appropriate conditions concerning recordkeeping and reporting, including records access by the Secretary, with respect to the emergency use of the product.
Note that this section is for Emergency Use Authorization (for the currently available vaccines) and includes informed consent and the option to refuse.
I underlined the part about "consequences, if any, of refusing administration of the product" because I believe this pertains to the medical "consequences" of not taking the drug. It does NOT give permission to businesses to place "consequences" on employees who don't take the drug. The former gives the recipient the choice, the latter is coercive consent under duress.
Nobody can give a legally binding consent under these conditions, and for that reason these mandates to take the EUA vaccines should be challenged in court.
-PJ
